As shown in the summary data (Fig. 5A), the combination of SM7L and S-TRAIL lead to the greatest reduction in viability of both GBM cell lines (U251–82%; U87–71%; Fig. 5A). This evidence concerns the gene TNFSF10 and glioblastoma.